Kimberly Cramer-Morales

945 total citations
8 papers, 229 citations indexed

About

Kimberly Cramer-Morales is a scholar working on Molecular Biology, Oncology and Geriatrics and Gerontology. According to data from OpenAlex, Kimberly Cramer-Morales has authored 8 papers receiving a total of 229 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 2 papers in Oncology and 1 paper in Geriatrics and Gerontology. Recurrent topics in Kimberly Cramer-Morales's work include DNA Repair Mechanisms (4 papers), DNA and Nucleic Acid Chemistry (3 papers) and CRISPR and Genetic Engineering (2 papers). Kimberly Cramer-Morales is often cited by papers focused on DNA Repair Mechanisms (4 papers), DNA and Nucleic Acid Chemistry (3 papers) and CRISPR and Genetic Engineering (2 papers). Kimberly Cramer-Morales collaborates with scholars based in United States, Poland and Austria. Kimberly Cramer-Morales's co-authors include Tomasz Skórski, Wayne E. Childers, Frederick E. Domann, Collin D. Heer, Kranti A. Mapuskar, David A. Ostrov, Robert Hromas, Katherine Sullivan, Mhairi Copland and Curt I. Civin and has published in prestigious journals such as Blood, PLoS ONE and Free Radical Biology and Medicine.

In The Last Decade

Kimberly Cramer-Morales

8 papers receiving 228 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kimberly Cramer-Morales United States 6 190 94 38 29 24 8 229
Katie Holmes United States 6 242 1.3× 56 0.6× 35 0.9× 35 1.2× 16 0.7× 13 311
Jinfeng Shen Sweden 5 216 1.1× 152 1.6× 36 0.9× 32 1.1× 13 0.5× 7 279
Stephanie Chrysanthou United States 8 275 1.4× 58 0.6× 31 0.8× 23 0.8× 19 0.8× 10 332
Takao Morinaga Japan 9 151 0.8× 70 0.7× 22 0.6× 29 1.0× 6 0.3× 23 229
Miriam Kull Germany 8 279 1.5× 61 0.6× 130 3.4× 17 0.6× 23 1.0× 16 335
Yiliang Wei United States 10 210 1.1× 70 0.7× 25 0.7× 40 1.4× 5 0.2× 14 261
Katarzyna Starowicz United Kingdom 7 260 1.4× 97 1.0× 20 0.5× 22 0.8× 12 0.5× 8 296
Céline Moison Canada 10 216 1.1× 51 0.5× 105 2.8× 36 1.2× 39 1.6× 17 295
Asuka Hira Japan 6 238 1.3× 32 0.3× 39 1.0× 75 2.6× 15 0.6× 9 293
Subbaiah Chary Nimmagadda Germany 9 120 0.6× 40 0.4× 47 1.2× 22 0.8× 21 0.9× 13 172

Countries citing papers authored by Kimberly Cramer-Morales

Since Specialization
Citations

This map shows the geographic impact of Kimberly Cramer-Morales's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kimberly Cramer-Morales with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kimberly Cramer-Morales more than expected).

Fields of papers citing papers by Kimberly Cramer-Morales

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kimberly Cramer-Morales. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kimberly Cramer-Morales. The network helps show where Kimberly Cramer-Morales may publish in the future.

Co-authorship network of co-authors of Kimberly Cramer-Morales

This figure shows the co-authorship network connecting the top 25 collaborators of Kimberly Cramer-Morales. A scholar is included among the top collaborators of Kimberly Cramer-Morales based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kimberly Cramer-Morales. Kimberly Cramer-Morales is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Cramer-Morales, Kimberly, Collin D. Heer, Kranti A. Mapuskar, & Frederick E. Domann. (2020). Succinate Accumulation Links Mitochondrial MnSOD Depletion to Aberrant Nuclear DNA Methylation and Altered Cell Fate. PubMed. 1(2). 60–70. 6 indexed citations
2.
Mott, Sarah L., Kimberly Cramer-Morales, Ann M. Miller, et al.. (2019). Nicotinamide phosphoribosyltransferase expression and clinical outcome of resected stage I/II pancreatic ductal adenocarcinoma. PLoS ONE. 14(3). e0213576–e0213576. 6 indexed citations
3.
Sullivan, Katherine, Kimberly Cramer-Morales, David A. Ostrov, et al.. (2016). Identification of a Small Molecule Inhibitor of RAD52 by Structure-Based Selection. PLoS ONE. 11(1). e0147230–e0147230. 55 indexed citations
4.
Cramer-Morales, Kimberly, Collin D. Heer, Kranti A. Mapuskar, & Frederick E. Domann. (2015). SOD2 targeted gene editing by CRISPR/Cas9 yields Human cells devoid of MnSOD. Free Radical Biology and Medicine. 89. 379–386. 22 indexed citations
5.
Sullivan, Katherine, Kimberly Cramer-Morales, David A. Ostrov, et al.. (2015). Identification of a Small Molecule Inhibitor of RAD52 to Induce Synthetic Lethality in BRCA-Deficient Leukemias. Blood. 126(23). 4434–4434. 1 indexed citations
6.
Vorrink, Sabine U., et al.. (2014). Aberrant CpG methylation of theTFAP2Agene constitutes a mechanism for loss ofTFAP2Aexpression in human metastatic melanoma. Epigenetics. 9(12). 1641–1647. 28 indexed citations
7.
Nieborowska-Skorska, Margaret, Katherine Sullivan, Paulina Podszywalow‐Bartnicka, et al.. (2014). Gene Expression and Mutation Analysis (GEMA) –Guided Precision Medicine Targeting PARP1 to Induce Synthetic Lethality in DNA-PK –Deficient Quiescent and BRCA-Deficient Proliferating Leukemia Stem and Progenitor Cells. Blood. 124(21). 480–480. 1 indexed citations
8.
Cramer-Morales, Kimberly, Margaret Nieborowska-Skorska, Kara Scheibner, et al.. (2013). Personalized synthetic lethality induced by targeting RAD52 in leukemias identified by gene mutation and expression profile. Blood. 122(7). 1293–1304. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katie Holmes Breakdown of academic impact, for papers by Jinfeng Shen Breakdown of academic impact, for papers by Stephanie Chrysanthou Breakdown of academic impact, for papers by Takao Morinaga Breakdown of academic impact, for papers by Miriam Kull Breakdown of academic impact, for papers by Yiliang Wei Breakdown of academic impact, for papers by Katarzyna Starowicz Breakdown of academic impact, for papers by Céline Moison Breakdown of academic impact, for papers by Asuka Hira Breakdown of academic impact, for papers by Subbaiah Chary Nimmagadda
Rankless by CCL
2026